FDA Inspection 1252211 — Zibo Xinhua Perrigo Pharmaceutical Company Ltd.
The FDA completed an inspection of Zibo Xinhua Perrigo Pharmaceutical Company Ltd. on Sep 6, 2024 in Zibo. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action). Product area: Drugs.
Inspection Details
- Classification
- Voluntary Action Indicated (VAI)
- End Date
- Sep 6, 2024
- Fiscal Year
- 2024
- Product Type
- Drugs
- Project Area
- Drug Quality Assurance
- Location
- Zibo (China)